EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Sergio Todde; Albert D. Windhorst; Martin Behe; Guy Bormans; Clemens Decristoforo; Alain Faivre-Chauvet; Valentina Ferrari; Antony D. Gee; Balazs Gulyas; Christer Halldin; Petra Kolenc Peitl; Jacek Koziorowski; Thomas L. Mindt; Martina Sollini; Johnny Vercouillie; James R. Ballinger; Philip H. Elsinga

doi:10.1007/s00259-014-2866-8

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Sergio Todde
, Albert D. Windhorst
, Martin Behe
, Guy Bormans
, Clemens Decristoforo
, Alain Faivre-Chauvet
, Valentina Ferrari
, Antony D. Gee
, Balazs Gulyas
, Christer Halldin
, Petra Kolenc Peitl
, Jacek Koziorowski
, Thomas L. Mindt
, Martina Sollini
, Johnny Vercouillie
, James R. Ballinger
, Philip H. Elsinga^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

36 Citations (Scopus)

Abstract

The preparation of an Investigational Medicinal Product Dossier (IMPD) for a radiopharmaceutical to be used in a clinical trial is a challenging proposition for radiopharmaceutical scientists working in small-scale radiopharmacies. In addition to the vast quantity of information to be assembled, the structure of a standard IMPD is not well suited to the special characteristics of radiopharmaceuticals. This guideline aims to take radiopharmaceutical scientists through the practicalities of preparing an IMPD, in particular giving advice where the standard format is not suitable. Examples of generic IMPDs for three classes of radiopharmaceuticals are given: a small molecule, a kit-based diagnostic test and a therapeutic radiopharmaceutical.

Original language	English
Pages (from-to)	2175-2185
Number of pages	11
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	41
Issue number	11
DOIs	https://doi.org/10.1007/s00259-014-2866-8
Publication status	Published - Nov-2014

Keywords

Radiopharmaceutical
Clinical trial
Investigational medicinal product
Guideline

Access to Document

10.1007/s00259-014-2866-8

Handle.net

Persistent link

Embargoed Document

EANM guideline for the preparation of an Investigational Medicinal Product Dossier
Final publisher's version, 207 KB
Request copy

Cite this

Todde, S., Windhorst, A. D., Behe, M., Bormans, G., Decristoforo, C., Faivre-Chauvet, A., Ferrari, V., Gee, A. D., Gulyas, B., Halldin, C., Peitl, P. K., Koziorowski, J., Mindt, T. L., Sollini, M., Vercouillie, J., Ballinger, J. R., & Elsinga, P. H. (2014). EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD). European Journal of Nuclear Medicine and Molecular Imaging, 41(11), 2175-2185. https://doi.org/10.1007/s00259-014-2866-8

@article{bea17425c3134fad8d02b848b42c8e5d,

title = "EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)",

abstract = "The preparation of an Investigational Medicinal Product Dossier (IMPD) for a radiopharmaceutical to be used in a clinical trial is a challenging proposition for radiopharmaceutical scientists working in small-scale radiopharmacies. In addition to the vast quantity of information to be assembled, the structure of a standard IMPD is not well suited to the special characteristics of radiopharmaceuticals. This guideline aims to take radiopharmaceutical scientists through the practicalities of preparing an IMPD, in particular giving advice where the standard format is not suitable. Examples of generic IMPDs for three classes of radiopharmaceuticals are given: a small molecule, a kit-based diagnostic test and a therapeutic radiopharmaceutical.",

keywords = "Radiopharmaceutical, Clinical trial, Investigational medicinal product, Guideline",

author = "Sergio Todde and Windhorst, \{Albert D.\} and Martin Behe and Guy Bormans and Clemens Decristoforo and Alain Faivre-Chauvet and Valentina Ferrari and Gee, \{Antony D.\} and Balazs Gulyas and Christer Halldin and Peitl, \{Petra Kolenc\} and Jacek Koziorowski and Mindt, \{Thomas L.\} and Martina Sollini and Johnny Vercouillie and Ballinger, \{James R.\} and Elsinga, \{Philip H.\}",

year = "2014",

month = nov,

doi = "10.1007/s00259-014-2866-8",

language = "English",

volume = "41",

pages = "2175--2185",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "11",

}

Todde, S, Windhorst, AD, Behe, M, Bormans, G, Decristoforo, C, Faivre-Chauvet, A, Ferrari, V, Gee, AD, Gulyas, B, Halldin, C, Peitl, PK, Koziorowski, J, Mindt, TL, Sollini, M, Vercouillie, J, Ballinger, JR & Elsinga, PH 2014, 'EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)', European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 11, pp. 2175-2185. https://doi.org/10.1007/s00259-014-2866-8

TY - JOUR

T1 - EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

AU - Todde, Sergio

AU - Windhorst, Albert D.

AU - Behe, Martin

AU - Bormans, Guy

AU - Decristoforo, Clemens

AU - Faivre-Chauvet, Alain

AU - Ferrari, Valentina

AU - Gee, Antony D.

AU - Gulyas, Balazs

AU - Halldin, Christer

AU - Peitl, Petra Kolenc

AU - Koziorowski, Jacek

AU - Mindt, Thomas L.

AU - Sollini, Martina

AU - Vercouillie, Johnny

AU - Ballinger, James R.

AU - Elsinga, Philip H.

PY - 2014/11

Y1 - 2014/11

N2 - The preparation of an Investigational Medicinal Product Dossier (IMPD) for a radiopharmaceutical to be used in a clinical trial is a challenging proposition for radiopharmaceutical scientists working in small-scale radiopharmacies. In addition to the vast quantity of information to be assembled, the structure of a standard IMPD is not well suited to the special characteristics of radiopharmaceuticals. This guideline aims to take radiopharmaceutical scientists through the practicalities of preparing an IMPD, in particular giving advice where the standard format is not suitable. Examples of generic IMPDs for three classes of radiopharmaceuticals are given: a small molecule, a kit-based diagnostic test and a therapeutic radiopharmaceutical.

AB - The preparation of an Investigational Medicinal Product Dossier (IMPD) for a radiopharmaceutical to be used in a clinical trial is a challenging proposition for radiopharmaceutical scientists working in small-scale radiopharmacies. In addition to the vast quantity of information to be assembled, the structure of a standard IMPD is not well suited to the special characteristics of radiopharmaceuticals. This guideline aims to take radiopharmaceutical scientists through the practicalities of preparing an IMPD, in particular giving advice where the standard format is not suitable. Examples of generic IMPDs for three classes of radiopharmaceuticals are given: a small molecule, a kit-based diagnostic test and a therapeutic radiopharmaceutical.

KW - Radiopharmaceutical

KW - Clinical trial

KW - Investigational medicinal product

KW - Guideline

U2 - 10.1007/s00259-014-2866-8

DO - 10.1007/s00259-014-2866-8

M3 - Article

SN - 1619-7070

VL - 41

SP - 2175

EP - 2185

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 11

ER -

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Abstract

Keywords

Access to Document

Handle.net

Embargoed Document

Fingerprint

Cite this